Nuray Acar Aydemir

Dr. Nuray Acar Aydemir


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
CBCemre Nur Balci
Cemre Nur Balci
NANuray Acar Aydemir
Nuray Acar Aydemir

1 September 2008 in Acta Histochemica
Verified
Journal Article
Closed access
NANuray Acar Aydemir
Nuray Acar Aydemir
EKEmin Turkay Korgun
Emin Turkay Korgun
SCSevil Cayli
Sevil Cayli
ZSZeliha Sahin
Zeliha Sahin
RDRamazan Demir
Ramazan Demir
IUIsmail Ustunel
Ismail Ustunel

15 May 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
KAKubra Aksu
Kubra Aksu
EGEzgi Golal
Ezgi Golal
MAMutay Aydın Aslan
Mutay Aydın Aslan
IUIsmail Ustunel
Ismail Ustunel
NANuray Acar Aydemir
Nuray Acar Aydemir

11 July 2011 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
EKEmin Türkay Korgun
Emin Türkay Korgun
NANuray Acar Aydemir
Nuray Acar Aydemir
LSLeyla Sati
Leyla Sati
DKDijle Kipmen-Korgun
Dijle Kipmen-Korgun
AOAsl Ozen
Asl Ozen
RDRamazan Demir
Ramazan Demir
In various tissues, glucocorticoids (GCs) are known to downregulate glucose transport systems; however, their effects on glucose transporters (GLUTs) in the placenta of a diabetic rat are unknown. Glucocorticoid hormone action within the cell is regulated by the glucocorticoid receptor (GR). Thus, this study was designed to investigate the relationship between GR and glucose transporter expression in the placenta of the diabetic rat. Our immunohistochemical results indicated that GR and glucose transporter protein 1 (GLUT 1) are expressed ubiquitously in the trophoblast and endothelial cells of the labyrinthine zone, where maternal fetal transport takes place in the rat placenta. Expression of GR in the junctional zone of the rat placenta was detected in giant cells, and in some spongiotrophoblast cells, but not in the glycogen cells. GLUT 1 was present, especially in glycogen cells during early pregnancy, and in the spongiotrophoblast cells of the junctional zone during late pregnancy. Amounts of GR and GLUT 1 protein were increased towards the end of gestation both in the control and the diabetic placenta. However, at days 17 and 19 of gestation, only the placental GR protein was significantly increased in the streptozotocin-induced diabetic rats compared to control rats. Diabetes led to a significant decrease in placental weight at gestation day 15. In contrast, at gestational days 17 and 21, the weights of the diabetic placenta were significantly increased as compared with the controls. Moreover, diabetes induced fetus intrauterine growth retardation at gestational days 13, 17 and 21. In conclusion, the localization pattern of GR and GLUT 1 proteins in the same cell types led us to believe that there might be a relationship between GR and GLUT 1 expressions at the cellular level. GLUT 1 does not play a pivotal role in diabetic pregnancies. However, placental growth abnormalities during diabetic pregnancy may be related to the amount of GR. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 2, pp. 325–334) In various tissues, glucocorticoids (GCs) are known to downregulate glucose transport systems; however, their effects on glucose transporters (GLUTs) in the placenta of a diabetic rat are unknown. Glucocorticoid hormone action within the cell is regulated by the glucocorticoid receptor (GR). Thus, this study was designed to investigate the relationship between GR and glucose transporter expression in the placenta of the diabetic rat. Our immunohistochemical results indicated that GR and glucose transporter protein 1 (GLUT 1) are expressed ubiquitously in the trophoblast and endothelial cells of the labyrinthine zone, where maternal fetal transport takes place in the rat placenta. Expression of GR in the junctional zone of the rat placenta was detected in giant cells, and in some spongiotrophoblast cells, but not in the glycogen cells. GLUT 1 was present, especially in glycogen cells during early pregnancy, and in the spongiotrophoblast cells of the junctional zone during late pregnancy. Amounts of GR and GLUT 1 protein were increased towards the end of gestation both in the control and the diabetic placenta. However, at days 17 and 19 of gestation, only the placental GR protein was significantly increased in the streptozotocin-induced diabetic rats compared to control rats. Diabetes led to a significant decrease in placental weight at gestation day 15. In contrast, at gestational days 17 and 21, the weights of the diabetic placenta were significantly increased as compared with the controls. Moreover, diabetes induced fetus intrauterine growth retardation at gestational days 13, 17 and 21. In conclusion, the localization pattern of GR and GLUT 1 proteins in the same cell types led us to believe that there might be a relationship between GR and GLUT 1 expressions at the cellular level. GLUT 1 does not play a pivotal role in diabetic pregnancies. However, placental growth abnormalities during diabetic pregnancy may be related to the amount of GR. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 2, pp. 325–334)

16 June 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
EGEzgi Golal
Ezgi Golal
CBCemre Nur Balci
Cemre Nur Balci
IUIsmail Ustunel
Ismail Ustunel
NANuray Acar Aydemir
Nuray Acar Aydemir

13 November 2022 in Annals of Anatomy - Anatomischer Anzeiger
Verified
Journal Article
Closed access
CBCemre Nur Balci
Cemre Nur Balci
EGEzgi Golal
Ezgi Golal
IUIsmail Ustunel
Ismail Ustunel
NANuray Acar Aydemir
Nuray Acar Aydemir